Medicine:Acute posterior multifocal placoid pigment epitheliopathy

From HandWiki
Short description: Eye disease causing lesions in retina
Acute posterior multifocal placoid pigment epitheliopathy
PMID20029144 08 acute posterior multifocal placoid pigment epitheliopathy.png
Placoid lesions seen on fundal examination in APMPPE
SpecialtyOphthalmology

Acute posterior multifocal placoid pigment epitheliopathy (APMPPE) is an acquired inflammatory uveitis that belongs to the heterogenous group of white dot syndromes in which light-coloured (yellowish-white) lesions begin to form in the macular area of the retina. Early in the course of the disease, the lesions cause acute and marked vision loss (if it interferes with the optic nerve) that ranges from mild to severe but is usually transient in nature. APMPPE is classified as an inflammatory disorder that is usually bilateral and acute in onset but self-limiting. The lesions leave behind some pigmentation, but visual acuity eventually improves even without any treatment (providing scarring doesn't interfere with the optic nerve).

It occurs equally between men and women with a male to female ratio of 1.2:1. Mean onset age is 27, but has been seen in people aged 16 to 40.[1] It is known to occur after or concurrently with a systemic infection (but not always), showing that it is related generally to an altered immune system. Recurrent episodes can happen, but are extremely rare.[2][3]

Signs and symptoms

The onset of ocular symptoms are usually preceded by episode of viral or flu-like symptoms such as fever, cough or sore throat (however this is not always the case). Patients can typically present erythema nodosum, livedo reticularis, bilateral uveitis, and sudden onset of marked visual loss associated with the appearance of multiple lesions in the retina. These lesions may be colored from grey-white to cream-shaded yellow. Other symptoms include scotomata and photopsia. In weeks to a month times the lesions begin to clear and disappear (with prednisone) leaving behind areas of retinal pigment epithelial atrophy and diffuse fine pigmentation (scarring). Rarely choroidal neovascularization occur as a late onset complication.[4]

Cause

Since The cause of the inflammation remains unknown, with various theories of it occurring as an autoimmune response to a mild infection, or the possibility of it being viral because of the preceding flu-like illness that generally accompanies it.[2][4] It is associated an increased incidence of both HLA-B7 and HLA-DR2.

The underlying etiology of APMPPE continues to cause debate.[5][6] The term 'Pigment Epitheliopathy' was chosen by Gass[7] to reflect what he thought was the tissue most significantly affected. Van Buskirk et al.,[8] and Deutman et al.[9] proposed choriocapillaris ischemia as the more likely primary etiology. Indocyanine green angiography (ICGA),[10] and OCT angiography (OCTA)[11][12][13] studies have provided support for choriocapillaris involvement.

However, a novel hypothesis was proposed implicating a direct neurotropic infection as a possible underlying cause given the dynamic changes observed along the neuronal pathway of the retina [14]

Diagnosis

Diagnosis is usually made on clinical appearance alone on fundoscopy and/or retinal imaging. Supplementary tests such as Optical coherence tomography(OCT) and fundus fluorescein angiography/Indocyanine angiography together with OCT-Angiography are commonly performed to help aid diagnosis and monitoring. Fundus photography is useful to document the appearance of APMPPE lesions.[1]

Management

The original description categorized APMPPE as a self-limiting condition with a good prognosis, but the disease can be recurrent and result in significant visual loss.[1] Owing to the self-limiting nature of the disease, treatment is generally not required. In cases where lesions appear to be interfering with the optic nerve, methyl prednisone is prescribed, but in recurrent disease an antimetabolite agent may be indicated.[1]

Prognosis

Vision improves in almost all cases. In rare cases, a patient may suffer permanent visual loss associated with lesions on their optic nerve.

Rarely, coexisting vasculitis may cause neurological complications. These occurrences can start with mild headaches that steadily worsen in pain and onset, and can include attacks of dysesthesia. This type of deterioration happens usually if the lesions involve the fovea.[2][15]

See also

References

  1. ↑ 1.0 1.1 1.2 1.3 "Acute posterior multifocal placoid pigment epitheliopathy (APMPPE)". J Ophthalmic Inflamm Infect 11 (1): 31. November 2021. doi:10.1186/s12348-021-00263-1. PMID 34524577. 
  2. ↑ 2.0 2.1 2.2 "Neurological manifestations of acute posterior multifocal placoid pigment epitheliopathy". Stroke 27 (5): 996–1001. May 1996. doi:10.1161/01.str.27.5.996. PMID 8623125. 
  3. ↑ Jones, Nicholas P (1995). "Acute posterior multifocal placoid pigment epitheliopathy". British Journal of Ophthalmology (BMJ group) 79 (4): 384–389. doi:10.1136/bjo.79.4.384. PMID 7742290. 
  4. ↑ 4.0 4.1 De Vries, J.J. (June 2006). "Acute Posterior Multifocal Placoid Pigment Epitheliopathy with Cerebral Vasculitis: A Multisystem Granulomatous Disease". Archives of Ophthalmology 124 (6): 910–913. doi:10.1001/archopht.124.6.910. PMID 16769850. http://archopht.ama-assn.org/cgi/content/full/124/6/910. Retrieved 2009-09-15. 
  5. ↑ "Renaming of Acute Posterior Multifocal Placoid Pigment Epitheliopathy (APMPPE) to Acute Multifocal Placoid Choroidopathy (AMP-C)". JAMA Ophthalmol 135 (3): 185. March 2017. doi:10.1001/jamaophthalmol.2016.5325. PMID 28097335. 
  6. ↑ "Keeping the Name of Acute Posterior Multifocal Placoid Pigment Epitheliopathy". JAMA Ophthalmol 135 (3): 186. March 2017. doi:10.1001/jamaophthalmol.2016.5334. PMID 28099970. 
  7. ↑ "Acute posterior multifocal placoid pigment epitheliopathy". Arch Ophthalmol 80 (2): 177–85. August 1968. doi:10.1001/archopht.1968.00980050179005. PMID 5661882. 
  8. ↑ "Pigmentary epitheliopathy and erythema nodosum". Arch Ophthalmol 85 (3): 369–72. March 1971. doi:10.1001/archopht.1971.00990050371025. PMID 5100807. 
  9. ↑ "Acute posterior multifocal placoid pigment epitheliopathy. Pigment epitheliopathy of choriocapillaritis?". Br J Ophthalmol 56 (12): 863–74. December 1972. doi:10.1136/bjo.56.12.863. PMID 4651978. 
  10. ↑ "Acute posterior multifocal placoid pigment epitheliopathy. An indocyanine green angiographic study". Retina 13 (4): 317–25. 1993. doi:10.1097/00006982-199313040-00009. PMID 8115733. 
  11. ↑ "Optical Coherence Tomography Angiography Reveals Choriocapillaris Flow Reduction in Placoid Chorioretinitis". Ophthalmol Retina 1 (1): 77–91. 2017. doi:10.1016/j.oret.2016.08.008. PMID 31047399. 
  12. ↑ "Multimodal Imaging in Acute Posterior Multifocal Placoid Pigment Epitheliopathy Demonstrating Obstruction of the Choriocapillaris". Ophthalmic Surg Lasers Imaging Retina 47 (7): 677–81. July 2016. doi:10.3928/23258160-20160707-12. PMID 27434902. https://research-information.bris.ac.uk/en/publications/38df13c2-6d88-4086-ada4-4c6190f74d42. 
  13. ↑ "Application of OCT-angiography to characterise the evolution of chorioretinal lesions in acute posterior multifocal placoid pigment epitheliopathy". Eye (Lond) 31 (10): 1399–1408. October 2017. doi:10.1038/eye.2017.180. PMID 28983094. 
  14. ↑ 1. Steptoe PJ, Pearce I, Beare NAV, Sreekantam S, Mohammed BR, Barry R, Steeples LR, Denniston AK. Proposing a Neurotropic Etiology for Acute Posterior Multifocal Placoid Pigment Epitheliopathy and Relentless Placoid Choroidopathy. Investigative Ophthalmology & Visual Science (2021) 62:3447–3447. doi:10.3389/fopht.2021.802962 https://www.frontiersin.org/articles/10.3389/fopht.2021.802962/full
  15. ↑ "Long-term visual function in acute posterior multifocal placoid pigment epitheliopathy". Arch Ophthalmol 109 (6): 800–3. June 1991. doi:10.1001/archopht.1991.01080060064025. PMID 2043067. 

External links

Classification
External resources



Retrieved from "https://handwiki.org/wiki/index.php?title=Medicine:Acute_posterior_multifocal_placoid_pigment_epitheliopathy&oldid=3270233"